Nippon Shinyaku Co Ltd (4516):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nippon Shinyaku Co Ltd (4516) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9910
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nippon Shinyaku Co Ltd (Nippon) is a pharmaceutical company that develops, manufactures and sells ethical pharmaceuticals and functional foods. The company offers a wide range of products including drugs for pain, inflammation, and allergies; urological diseases; hematologic malignancies; gastrointestinal disorders; cardiovascular and metabolic diseases among others. Nippon also provides functional food ingredients including health food ingredients, preservatives, spices and condiments, and protein preparations. Its functional food products find application in meat processing, fish processing, dairy product, prepared food, confectionery and bakery, and beverage, among others. The company operates business through a network of offices and research laboratories in Japan, China, the UK and the US. Nippon is headquartered in Minami-ku, Kyoto, Japan.

Nippon Shinyaku Co Ltd (4516) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Nippon Shinyaku Enters into Co-Promotion Agreement with Merck Serono 10
National Center of Neurology and Psychiatry and Nippon Shinyaku Enter into Co-Development Agreement 11
Chugai Pharma Enters Into Co-Development Agreement With Nippon Shinyaku For GA101 12
Licensing Agreements 13
Nippon Shinyaku Enters into Licensing Agreement with Jazz Pharma 13
Nippon Shinyaku Enters into a Licensing Agreement with Delta-Fly Pharma 14
Nippon Shinyaku Enters into Licensing Agreement with Pharmacosmos for Monofer 15
Dainippon Sumitomo Pharma Enters Into Licensing Agreement With Nippon Shinyaku For SMP-986 16
Nippon Shinyaku Co Ltd – Key Competitors 17
Nippon Shinyaku Co Ltd – Key Employees 18
Nippon Shinyaku Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nippon Shinyaku Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nippon Shinyaku Enters into Co-Promotion Agreement with Merck Serono 10
National Center of Neurology and Psychiatry and Nippon Shinyaku Enter into Co-Development Agreement 11
Chugai Pharma Enters Into Co-Development Agreement With Nippon Shinyaku For GA101 12
Nippon Shinyaku Enters into Licensing Agreement with Jazz Pharma 13
Nippon Shinyaku Enters into a Licensing Agreement with Delta-Fly Pharma 14
Nippon Shinyaku Enters into Licensing Agreement with Pharmacosmos for Monofer 15
Dainippon Sumitomo Pharma Enters Into Licensing Agreement With Nippon Shinyaku For SMP-986 16
Nippon Shinyaku Co Ltd, Key Competitors 17
Nippon Shinyaku Co Ltd, Key Employees 18
Nippon Shinyaku Co Ltd, Other Locations 19
Nippon Shinyaku Co Ltd, Subsidiaries 20

List of Figures
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Nippon Shinyaku Co Ltd (4516):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stantec Inc (STN):電力:M&Aディール及び事業提携情報
    Summary Stantec Inc. (Stantec) is a construction and consulting services company. The company offers architectural, engineering, and environmental services. Its service portfolio includes architecture and interior design, building engineering, community design services, geomatics, geotechnical engin …
  • Petroleos de Venezuela SA-石油・ガス分野:企業M&A・提携分析
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • Infant Bacterial Therapeutics AB (IBT B):企業の財務・戦略的SWOT分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • China Communications Construction Co Ltd:戦略・SWOT・企業財務分析
    China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Varian Medical Systems, Inc.:企業のM&A・事業提携・投資動向
    Varian Medical Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Varian Medical Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Ventas Inc:企業のM&A・事業提携・投資動向
    Ventas Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ventas Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • McCarthy Building Companies Inc:企業の戦略的SWOT分析
    McCarthy Building Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Promius Pharma LLC-製薬・医療分野:企業M&A・提携分析
    Summary Promius Pharma LLC (Promius Pharma) a subsidiary of Dr. Reddy's Laboratories Ltd is a provider of dermatology and neurology products. The company’s products include clocortolone pivalate, promiseb topical cream, coal tar, betamethasone dipropionate, triamcinolone acetonide ointment, USP, su …
  • Zahroof Valves Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Zahroof Valves Inc (Zahroof Valves) is a manufacturer and supplier of industrial valves. The company offers straightflo valve (SF) for use in reciprocating gas compressors. Its valves are used in gas production, gas gathering, gas transmission, gas storage and gas distribution applications. …
  • Energy Transfer Equity, L.P.:企業のM&A・事業提携・投資動向
    Energy Transfer Equity, L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Energy Transfer Equity, L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Tiscali Group:企業の戦略・SWOT・財務分析
    Tiscali Group - Strategy, SWOT and Corporate Finance Report Summary Tiscali Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Orion New Zealand Ltd:企業の戦略的SWOT分析
    Orion New Zealand Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Tristan Technologies Inc:企業の製品パイプライン分析
    Summary Tristan Technologies Inc (Tristan) is a medical device company that offers laboratory products. The company designs, develops and manufactures components and systems for biomagnetic measurement and clinical applications. Its products comprise biomagnetic devices, geomagnetic, cryogenic, non- …
  • Dongfang Electric Corporation Ltd (1072):企業の財務・戦略的SWOT分析
    Dongfang Electric Corporation Ltd (1072) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Imagion Biosystems Inc:製品パイプライン分析
    Summary Imagion Biosystems Inc (Imagion Biosystems), formerly Senior Scientific LLC, a subsidiary of Manhattan Scientifics Inc, is a biomedical equipment provider that offers nanomagnetic particle detection systems. The company offers nanomagnetic relaxometry method for cancer detection and precisio …
  • MTU Aero Engines Holdings AG (MTX):企業の財務・戦略的SWOT分析
    MTU Aero Engines Holdings AG (MTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Edcon Holdings (Proprietary) Limited:企業の戦略・SWOT・財務分析
    Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report Summary Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Seventh Sense Biosystems Inc-医療機器分野:企業M&A・提携分析
    Summary Seventh Sense Biosystems Inc (Seventh Sense) is a medical device company that develops and markets blood collection devices. The company’s products comprise testing devices, TAP devices, sterile and microneedle arrays among others. It uses TAP Touch Activated Phlebotomy painless blood collec …
  • Rowan Companies plc:企業の戦略・SWOT・財務情報
    Rowan Companies plc - Strategy, SWOT and Corporate Finance Report Summary Rowan Companies plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Global Tungsten & Powders Corp.:企業の戦略・SWOT・財務情報
    Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report Summary Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆